Novel Oral Therapy For Ms: Aan Data Updates

Novel Oral Therapy for MS: AAN Data Updates

Charting a new course for Multiple Sclerosis (MS) treatment

Faculty of Medicine at UBC

AAN Clinical Practice Guideline: Disease-modifying Therapies for Multiple Sclerosis (Brain&Life)

Brain & Life Magazine

Marisa McGinley, AAN 2019 – Latest developments in the treatment of multiple sclerosis

Touch Medical Media

AAN Releases Guideline: Disease-modifying Therapies for Adults with Multiple Sclerosis

Best MS Medication?

Aaron Boster MD

AAN 2020 Data Release: Ofatumumab for Relapsing MS

Positive Phase II data of novel anti-CD40L antibody frexalimab in MS

Clinical Implications of Late-Breaking Data on Disease Modifying Therapies for MS Management

Fernando Dangond, AAN 2019 – Phase II study of first oral BTK inhibitor in multiple sclerosis

Touch Medical Media

Ocrevus Infusion Done | Feeling Better Already!

AAN 2020: Real-World Data on Cladribine Tablets for MS

Debate on the NHS England algorithm for MS treatment by disease-modifying drugs

Neurology Academy

Multiple Sclerosis: Diagnosis and treatment plans - New Day NW

Cherie C. Binns, RN, MSCN: What's New In MS Treatment? June 2024

Multiple Sclerosis Foundation

New MS Medication 💊?

Aaron Boster MD

New Data Support Benefit of Ocrevus for Relapsing, Primary Progressive Multiple Sclerosis

Current and emerging treatment for MS in Australia - An update

Treatment of Multiple Sclerosis